Beyond anatomy: MR imaging as a molecular diagnostic tool

Surgical Oncology Clinics of North America

Volumn 8, Issue 1, 1999, Pages 171-183

  Calvo, B F ^a   Semelka, R C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURGERY; COMPUTER AIDED DESIGN; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DIAGNOSTIC VALUE; IMAGE QUALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASTIC SURGERY; REVIEW;

EID: 0032964079     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30231-x     Document Type: Review

References (46)

1. Arap W. Paqualini R. Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279 1988 377 380
2. Atlas S. Braffman B. LoBrutto R. Human malignant melanomas with varying degrees of melanin content in nude mice: MR imaging, histopathology, and electron paramagnetic resonance J Comput Assist Tomogr 14 1990 547
3. Bhakoo K.K. Williams S.R. Florian C.L. Immortalization and transformation are associated with specific alterations in choline metabolism Cancer Res 56 1996 4630 4635
4. Bilaniuk L. Atlas S. Magnetic resonance imaging of the orbit Radiol Clin North Am 25 1987 509
5. 19F nuclear magnetic resonance spectroscopy Int J Radiat Oncol Biol Phys 3 1996 641 648
6. Bloch R. Hansen W.W. Paxkard M. Nuclear Induction Physiol Rev 69 1946 127
7. Brooks P.C. Clark R.A. Cheresh D.A. Requirement of vascular integrin alpha v beta 3 for angiogenesis Science 264 1994 569
8. Castillo M. Kwock L. Mukherji S.K. Clinical applications of proton MR spectroscopy AJNR Am J Neuroradiol 17 1996 1 15
9. Enochs W.S. Hyslop W.B. Bennet H.F. Sources of the increased longitudinal relaxation rates observed in melanotic melanoma. An in vitro study of synthetic melanins Invest Radiol 24 1989 794 804
10. Enochs W.S. Petherick P. Bogdanova A. Paramagnetic metal scavenging by melanin: MR imaging Radiology 204 1997 417
11. Folkman J. Addressing tumor blood vessels [comment] Nature Biotechnol 15 1997 510
12. Gohr-Rosenthal S. Schmitt-Willich H. Ebert W. The demonstration of human tumors on nude mice using gadolinium-labeled monoclonal antibodies for magnetic resonance imaging Invest Radiol 28 1993 789 795
13. Gupta H. Weissleder R. Targeted contrast agents in MR imaging Magn Reson Imaging Clin North Am 4 1996 171 184
14. Huan L. Forum liposomes in diagnostic imaging Journal of Liposome Research 4 1994 741
15. Kabalka G.W. Buonocore E. Hubner K. Gadolinium-labeled liposomes containing paramagnetic amphiphatic agents: Targeted MRI contrast agents for the liver Magn Reson Med 8 1988 89 95
16. Kim C.J. Cormier J. Roden M. Use of recombinant poxviruses to stimulate antimelanoma T cell reactivity Ann Surg Oncol 5 1998 64 76
17. Kim C.J. Prevette T. Cormier J. Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro J Immunother 20 1997 276 286
18. Larsson B. Interaction between chemicals and melanin Pigment Cell Res 6 1993 127
19. Li Volsi V.A. Follicular lesions of the thyroid Surgical Pathology of the Thyroid 1990 WB Saunders Philadelphia 173 212
20. Mackinno W.B. Russel P. May G.L. Characterization of human ovarian epithelial tumors (ex-vivo) by proton magnetic resonance spectroscopy International Journal of Gynecologic Cancer 5 1995 211 221
21. Mackinnon W.B. Barry P.A. Malycha P.L. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy Radiology 204 1997 661 666
22. Mahfouz A.E. Hamm B. Taupitz M. Hepatic magnetic resonance imaging: New techniques and contrast agents Endoscopy 29 1997 504
23. Mazzaferri E.L. Thyroid cancer in thyroid nodules: finding a needle in the haystack Am J Med 93 1992 359 362
24. Matsumura A. Shibata Y. Nakagawa K. MRI contrast enhancement by Gd-DTPA-monoclonal antibody in 9L glioma rats Acta Neurochir 60 Suppl 1994 356 358
25. Mohler J. Sharieff Y. Flow cytometric assay of pinocytosis: Correlation with membrane ruffling and metastatic potential I the Dunning R-3327 rat prostatic adenocarcinoma model Cytometry 14 1993 826 831
26. Mukherji S.K. Schiro S. Castillo M. Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: In vitro characteristics AJNR Am J Neuroradiol 17 1996 1485 1490
27. Pauser S. Reszka R. Wagner S. Liposome-encapsulated superparamagnetic iron oxide particles as markers in an MRI-guided search for tumor-specific drug carriers Anticancer Drug Des 12 1997 125
28. Protor W.G. Yu F.C. The dependence of nuclear magnetic resonance frequency upon chemical shift Physiol Rev 70 1950 717
29. Purcell E.M. Torrey H.C. Pound R.V. Resonance absorption by nuclear magnetic moments in solids Physiol Rev 69 1946 37 38
30. Reimer P. Weissleder R. Wittenbert J. Receptor-directed contrast agents for MR Imaging: Preclinical Evaluation with Affinity Assays Radiology 182 1992 565 569
31. Reimer P. Weissleder R. Shen T. Pancreatic receptors: Initial feasibility studies with a targeted contrast agent for MR imaging Radiology 193 1994 527 531
32. Riederer S.J. Recent technical advances in MR imaging of the abdomen [review] J Magn Reson Imaging 6 1996 822 832
33. Rosenberg S.A. Yang J.C. Schwartzentruber Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma Nat Med 4 1998 321 327
34. Russell P. Lean C.L. Delbridge L. Proton magnetic resonance and human thyroid neoplasia I: Discrimination between benign and malignant neoplasms Am J Med 96 1994 383 388
35. Saini S. Edelman R.R. Sharma P. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: Initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227) AJR Am J Roentgenol 164 1995 1147
36. Schse A. Leike J.U. Robling G.L. Preparation and evaluation of lyophilized lopromide-carrying liposomes for liver tumor detection Invest Radiol 28 1993 838
37. Shen T.T. Bogdanov A. Bogdanova A. Magnetically labeled Secretin retains receptor affinity to pancreas acinar cells Bioconjug Chem 7 1996 311 316
38. Trubetskoy V.S. Cannillo J.A. Milshtein A. Controlled delivery of Gd-containing liposomes to lymph nodes: Surface modification may enhance MRI contrast properties Magn Reson Imaging 13 1995 31 37
39. Unger E. Shen D.K. Wu G. Liposomes as MR contrast agents: Pros and cons Magn Reson Med 22 1991 304 308
40. Vigneraon D.B. Nelson S.J. Kurhanewicz J. Higgins C.B. Hricak D. Helms C.A. Magnetic Resonance Imaging of the Body ed 3 1997 Lippincott-Raven Press New York 205 220
41. Wallace J.C. Raaphorst G.P. Somorjai R.L. Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis Magn Reson Med 38 1997 569 576
42. Weissleder R. Cheng H.C. Bogdanova A. Magnetically labeled cells can be detected by MR imaging J Magn Reson Imaging 7 1997 258
43. Weissleder R. Reimer P. Lee A.A. MR Receptor Imaging: Ultrasmall Iron Oxide Particles targeted to asialoglycoprotein receptors AJR Am J Roentgenol 155 1990 1161
44. Weissleder R. Simonova M. Bogdanova A. MR imaging and scintigraphy of gene expression through melanin induction Radiology 204 1997 425
45. Weissleder R. Stark D. Englestad B. Superparamagnetic iron oxide: Pharmacokinetics and toxicity AJR Am J Roentgenol 152 1989 167
46. Zimmer C. Wright S.C. Engelhardt R.T. Tumor cell endocytosis imaging facilitates delineation of the glioma-brain interface Exp Neurol 143 1997 61